Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats

Published:2009-06-24 Issue:1 Volume:10 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Chen Lei,Wang Tao,Wang Xun,Sun Bei-Bei,Li Ji-Qiong,Liu Dai-Shun,Zhang Shang-Fu,Liu Lin,Xu Dan,Chen Ya-Juan,Wen Fu-Qiang

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/1465-9921-10-55.pdf

Reference37 articles.

1. Cook DN, Brass DM, Schwartz DA: A Matrix for New Ideas in Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2002,27(2):122–124.

2. Ulrich P, Cerami A: Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001, 56:1–21.

3. Bohlender JM, Franke S, Stein G, Wolf G: Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005, 289:F645-F659.

4. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM: Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005,15(7):16R-28R.

5. Matsuse T, Ohga E, Teramoto S, Fukayama M, Nagai R, Horiuchi S, Ouchi Y: Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis. J Clin Pathol. 1998,51(7):515–519.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TMEM176B Prevents and alleviates bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor β-Smad signaling;Heliyon;2024-08

2. Breath of fresh air: Investigating the link between AGEs, sRAGE, and lung diseases;Vitamins and Hormones;2024

3. POLYPHENOLS OF NATURAL ORIGIN AGAINST AGE-RELATED DISORDERS OF TISSUE HOMEOSTASIS;Успехи геронтологии;2023-10-27

4. The melatonin agonist ramelteon attenuates bleomycin-induced lung fibrosis by suppressing the NLRP3/TGF-Β1/HMGB1 signaling pathway;Advances in Medical Sciences;2023-09

5. HSP47: A Therapeutic Target in Pulmonary Fibrosis;Biomedicines;2023-08-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3